It is not intended for human consumption, medical use, diagnostic use, therapeutic use, weight-loss use, appetite-control use, glucose-management use, diabetes treatment use, obesity treatment use, metabolic treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease
Transcriptomic analyses demonstrate upregulation of protective genes and suppression of oxidative injury pathways
Clinical results show an average weight loss of 20.9% for participants on a high-dose regimen
COPY THE URL BELOW
Medical oversight, proper dosing protocols, side effect management, and ongoing support significantly impact both safety and results
The results showed that most patients did not experience a worsening of their asthma symptoms while taking semaglutide